Glenmark Pharmaceuticals' consolidated net profit surged more than sixty four times to Rs 301.41 crore in Q4 FY26 from Rs 4.65 core posted in Q4 FY25.
Market Samachar is a news aggregator. This article was originally published by Markets. Tap the button above to read the full story on their site.